Variation in allergen content in sublingual allergen immunotherapy with house dust mites

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 11, 2015, Pages 1413-1420

  Moreno Benitez F ^a,b   Espinazo Romeu, M ^a,b   Letran Camacho A ^a,b   Mas, S ^c   Garcia Cozar F J ^b,d   Tabar, A I ^e,f  

^a Doctor Lobatón Clinic   (Spain)

^b UNIVERSITY OF CÁDIZ   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

^e UNIVERSITY OF NAVARRA   (Spain)

^f Recinto de Complejo Hospitalario de Navarra   (Spain)

Author keywords

allergen content; efficacy; evidence based medicine; house dust mites' sublingual allergen immunotherapy; weekly dosage

Indexed keywords

ALLERGEN; HOUSE DUST ALLERGEN; VACCINE;

ARTICLE; CONCENTRATION (PARAMETERS); DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DRUG EFFICACY; HOUSE DUST ALLERGY; HUMAN; IMMUNOBLOTTING; IMMUNOTHERAPY; MAINTENANCE DRUG DOSE; META ANALYSIS; MOLECULAR WEIGHT; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT DURATION; ANIMAL; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; PROCEDURES; PYROGLYPHIDAE; SUBLINGUAL IMMUNOTHERAPY; TREATMENT OUTCOME;

ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; HUMANS; HYPERSENSITIVITY; PYROGLYPHIDAE; SUBLINGUAL IMMUNOTHERAPY; TREATMENT OUTCOME; VACCINES;

EID: 84945494064     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12694     Document Type: Article

References (31)

1. Lizaso MT, Garcia BE, Tabar AI, Lasa E, Echechipia S, Alvarez MJ, et al., Comparison of conventional and component-resolved diagnostics by two different methods (Advia-Centaur/Microarray-ISAC) in pollen allergy. Ann Allergy Asthma Immunol 2011; 107: 35-41.
2. Sastre J, Landivar ME, Ruiz-Garcia M, Andregnette-Rosigno MV, Mahillo I,. How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area. Allergy 2012; 67: 709-711.
3. Letran A, Espinazo M, Moreno F,. Measurement of IgE to pollen allergen components is helpful in selecting patients for immunotherapy. Ann Allergy Asthma Immunol 2013; 111: 295-297.
4. Moreno C, Justicia JL, Quiralte J, Moreno-Ancillo A, Iglesias-Cadarso A, Torrecillas M, et al., Olive, grass or both? Molecular diagnosis for the allergen immunotherapy selection in polysensitized pollinic patients. Allergy 2014; 69: 1357-1363.
5. European Medicines Agency (EMEA). Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases; EMEA/CHMP/EWP/18504/2006 2008 [cited; Available from: http://www.emea.europa.eu/pdfs/human/ewp/1850406enfin.pdf
6. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS,. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312: 71-72.
7. Calderon MA, Casale TB, Nelson HS, Demoly P,. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. J Allergy Clin Immunol 2013; 132: 1322-1336.
8. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al., Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-178.
9. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al., Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010; 126: 466-476.
10. Larenas-Linnemann D, Esch R, Plunkett G, Brown S, Maddox D, Barnes C, et al., Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units. Ann Allergy Asthma Immunol 2011; 107: 448-458.
11. Larenas-Linnemann D, Cox LS,. European allergen extract units and potency: review of available information. Ann Allergy Asthma Immunol 2008; 100: 137-145.
12. Chapman MD, Ferreira F, Villalba M, Cromwell O, Bryan D, Becker WM, et al., The European Union CREATE project: a model for international standardization of allergy diagnostics and vaccines. J Allergy Clin Immunol 2008; 122: 882-889.
13. van Ree R, Chapman MD, Ferreira F, Vieths S, Bryan D, Cromwell O, et al., The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy 2008; 63: 310-326.
14. Casset A, Mari A, Purohit A, Resch Y, Weghofer M, Ferrara R, et al., Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts. Int Arch Allergy Immunol 2012; 159: 253-262.
15. Glyk A, Heinisch SL, Scheper T, Beutel S,. Comparison of colorimetric methods for the quantification of model proteins in aqueous two-phase systems. Anal Biochem 2015; 477: 35-37.
16. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al., Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76-85.
17. Bronner V, Denkberg G, Peled M, Elbaz Y, Zahavi E, Kasoto H, et al., Therapeutic antibodies: discovery and development using the ProteOn XPR36 biosensor interaction array system. Anal Biochem 2010; 406: 147-156.
18. Nahshol O, Bronner V, Notcovich A, Rubrecht L, Laune D, Bravman T,. Parallel kinetic analysis and affinity determination of hundreds of monoclonal antibodies using the ProteOn XPR36. Anal Biochem 2008; 383: 52-60.
19. Jeong KY, Lee IY, Yong TS, Lee JH, Kim EJ, Lee JS, et al., Sequence polymorphisms of Der f 1, Der p 1, Der f 2 and Der p 2 from Korean house dust mite isolates. Exp Appl Acarol 2012; 58: 35-42.
20. Jeong KY, Choi SY, Lee JH, Lee IY, Yong TS, Lee JS, et al., Standardization of house dust mite extracts in Korea. Allergy Asthma Immunol Res 2012; 4: 346-350.
21. Takai T, Kato T, Yasueda H, Okumura K, Ogawa H,. Analysis of the structure and allergenicity of recombinant pro- and mature Der p 1 and Der f 1: major conformational IgE epitopes blocked by prodomains. J Allergy Clin Immunol 2005; 115: 555-563.
22. Rebe Raz S, Liu H, Norde W, Bremer MG,. Food allergens profiling with an imaging surface plasmon resonance-based biosensor. Anal Chem 2010; 82: 8485-8491.
23. Gieras A, Cejka P, Blatt K, Focke-Tejkl M, Linhart B, Flicker S, et al., Mapping of conformational IgE epitopes with peptidic-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface path on the major birch pollen allergen, Bet v 1. J Immunol 2011; 186: 5333-5344.
24. James LK, Bowen H, Calvert RA, Dodev TS, Shamji MH, Beavil AJ, et al., Allergen specificity of IgG(4)-expressing B cells in patients with grass pollen allergy undergoing immunotherapy. J Allergy Clin Immunol 2012; 130: 663-670.
25. Avula-Poola S, Morgan MS, Arlian LG,. Diet influences growth rates and allergen and endotoxin contents of cultured Dermatophagoides farinae and Dermatophagoides pteronyssinus house dust mites. Int Arch Allergy Immunol 2012; 159: 226-234.
26. Iraola V, Gallego MT, Taules M, Carnes J,. Measurement of immunoglobulin E interaction with allergen extracts by surface plasmon resonance biosensor analysis. Ann Allergy Asthma Immunol 2013; 111: 228-229.
27. Mosges R, Pasch N, Schlierenkamper U, Lehmacher W,. Comparison of the biological activity of the most common sublingual allergen solutions made by two European manufacturers. Int Arch Allergy Immunol 2006; 139: 325-329.
28. Brunetto B, Tinghino R, Braschi MC, Antonicelli L, Pini C, Iacovacci P,. Characterization and comparison of commercially available mite extracts for in vivo diagnosis. Allergy 2010; 65: 184-190.
29. Lin SY, Erekosima N, Suarez-Cuervo C, Ramanathan M, Kim JM, Ward D, et al., Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review. Comparative Effectiveness Review No. 111. AHRQ Publication No. 13-EHC061-EF. Rockville, MD: Agency for Healthcare Research and Quality. March 2013. www.effectivehealthcare.ahrq.gov/reports/final.cfm.
30. Sander I, Fleischer C, Meurer U, Bruning T, Raulf-Heimsoth M,. Allergen content of grass pollen preparations for skin prick testing and sublingual immunotherapy. Allergy 2009; 64: 1486-1492.
31. Wise SK, Schlosser RJ,. Subcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence? Am J Rhinol Allergy 2012; 26: 18-22.